Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Liver diseases are on the rise, leading to about 2 million deaths each year globally, according to 2023 data. This is about 4 ...

A recent study published in Life Metabolism by researchers from the Affiliated Hospital of Nantong University has identified ...

Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United ...

For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, is returning to The Liver Meeting® (TLM) 2025, hosted by the American Association for the Study of Liver ...

The La Bodega clinic in Buffalo, a national model for treating liver disease along with overlapping conditions, is working to ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...